v3.26.1
Revenue (Details) - USD ($)
3 Months Ended
Feb. 18, 2026
Mar. 31, 2026
Revenue    
License Revenue   $ 300,000
License agreement with Rasayana Therapeutics, Inc.    
Revenue    
Upfront payments received $ 300,000  
Potential development milestone payments 16,000,000  
Potential sales milestone payments $ 22,000,000  
License Revenue   $ 300,000